检索结果 - Ke‐Neng Chen

Refine Results
  1. 1
    Association between H3K4 methylation and cancer prognosis: A meta-analysis

    Association between H3K4 methylation and cancer prognosis: A meta-analysis 由 Simin Li, Luyan Shen, Ke‐Neng Chen

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients with Esophageal Squamous Cell Carcinoma

    HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients with Esophageal Squamous Cell Carcinoma 由 Zhen‐Dong Gu, Luyan Shen, Hua Wang, Xiaomei Chen, Yong Li, Tao Ning, Ke‐Neng Chen

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China

    Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China 由 Tao Li, Zeng Lü, Ke‐Neng Chen, Mei Guo, Haiping Xing, Mei Qiang, Huai-Hua Yang, John F. Lechner, Yang Ke

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus

    Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus 由 Junsheng Fu, Zhaohui Xiong, Caizhi Huang, Jing Li, Wenjun Yang, Yuning Han, Chorlada Paiboonrungruan, Michael B. Major, Ke‐Neng Chen, Xiaozheng Kang, Xiaoxin Chen

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Cross-Platform Comparison of Four Leading Technologies for Detecting <i>EGFR</i> Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma

    Cross-Platform Comparison of Four Leading Technologies for Detecting <i>EGFR</i> Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma 由 Ting Xu, Xiaozheng Kang, Xiaofang You, Liang Dai, Dequan Tian, Wanpu Yan, Yongbo Yang, Hongchao Xiong, Zhen Liang, Grace Zhao, Shengrong Lin, Ke‐Neng Chen, Guobing Xu

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial

    Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial 由 Wanpu Yan, Wen‐Zhao Zhong, Yan‐Hui Liu, Qixun Chen, Wenqun Xing, Qin Zhang, Lunxu Liu, Di Ge, Ke‐Neng Chen, Fan Yang, Xiang Lin, Li Song, Wei Shi, Yi‐Long Wu

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer

    Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer 由 Hua Bai, Zhijie Wang, Ke‐Neng Chen, Jun Zhao, J. Jack Lee, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Li Mao, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang, Xiaozheng Kang, Jie Wang

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis

    Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis 由 Zhitao Gu, Jianhua Fu, Yi Shen, Yucheng Wei, Lijie Tan, Peng Zhang, Yongtao Han, Chun Chen, Renquan Zhang, Yin Li, Ke‐Neng Chen, Hezhong Chen, Yongyu Liu, Youbing Cui, Yun Wang, Liewen Pang, Zhentao Yu, Xinming Zhou, Yangchun Liu, Yu Liu, Wentao Fang

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study

    A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study 由 Hui Liu, Zhitao Gu, Bo Qiu, Frank C. Detterbeck, Anja C. Roden, Enrico Ruffini, Meinoshin Okumura, Nicolas Girard, Yangwei Xiang, Yu Liu, Zhicheng Du, Yuantao Hao, Jianhua Fu, Peng Zhang, Liewen Pang, Ke‐Neng Chen, Yun Wang, Zhentao Yu, Teng Mao, Wentao Fang

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Perioperative outcomes and long-term survival in clinically early-stage thymic malignancies: video-assisted thoracoscopic thymectomy versus open approaches

    Perioperative outcomes and long-term survival in clinically early-stage thymic malignancies: video-assisted thoracoscopic thymectomy versus open approaches 由 Hao Wang, Zhitao Gu, Jianyong Ding, Lijie Tan, Jianhua Fu, Yi Shen, Yucheng Wei, Peng Zhang, Yongtao Han, Chun Chen, Renquan Zhang, Yin Li, Ke‐Neng Chen, Hezhong Chen, Yongyu Liu, Youbing Cui, Yun Wang, Liewen Pang, Zhentao Yu, Xinming Zhou, Yangchun Liu Liu, Yu Liu, Wentao Fang

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Diagnosis, assessment, and management of surgical complications following esophagectomy

    Diagnosis, assessment, and management of surgical complications following esophagectomy 由 Peter Grimminger, Lucas Goense, Ines Gockel, Damien Bergeat, Nicolas Bertheuil, Servarayan Murugesan Chandramohan, Ke‐Neng Chen, Seung‐Hun Chon, Denis Collet, Khean‐Lee Goh, Caroline Gronnier, J F Liu, Bernard Meunier, P. Nafteux, Enrique D Pirchi, Marc Schiesser, René Thieme, Aaron Wu, Peter Wu, Navtej Buttar, Andrew C. Chang

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases

    Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases 由 Di Wang, Xiaohui Niu, Zhijie Wang, Chengli Song, Zhen Huang, Ke‐Neng Chen, Jianchun Duan, Hua Bai, Jiachen Xu, Jun Zhao, Yu Wang, Minglei Zhuo, X. Sunney Xie, Xiaozheng Kang, Yanhua Tian, Liangliang Cai, Jiefei Han, Tongtong An, Yu Sun, Shugeng Gao, Jun Zhao, Jianming Ying, Lühua Wang, Jie He, Jie Wang

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

    Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Stu... 由 Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen, Chundong Gu, Jun Wang, Xue‐Ning Yang, Weimin Mao, Qun Wang, Guibin Qiao, Ying Cheng, Lin Xu, Changli Wang, Mingwei Chen, Xiaozheng Kang, Wanpu Yan, Hong‐Hong Yan, Ri-Qiang Liao, Jin‐Ji Yang, Xu‐Chao Zhang, Qing Zhou, Yi‐Long Wu

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG... 由 Wen‐Zhao Zhong, Hong‐Hong Yan, Ke‐Neng Chen, Chun Chen, Chundong Gu, Jun Wang, Xue‐Ning Yang, Weimin Mao, Qun Wang, Guibin Qiao, Ying Cheng, Lin Xu, Changli Wang, Mingwei Chen, Xiaozheng Kang, Wanpu Yan, Ri-Qiang Liao, Jin‐Ji Yang, Xu‐Chao Zhang, Si‐Yang Liu, Qing Zhou, Yi‐Long Wu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial

    Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial 由 Yong Li, Aiping Zhou, Shuoyan Liu, Ming He, Ke‐Neng Chen, Ziqiang Tian, Yin Li, Jianjun Qin, Zhen Wang, Haiquan Chen, Hui Tian, Yue Yu, Wang Qu, Liyan Xue, Shun He, Shuhang Wang, Fenglong Bie, Guangyu Bai, Bolun Zhou, Zhaoyang Yang, Huiyao Huang, Yan Fang, Benjamin Li, Xiangrong Dai, Shugeng Gao, Jie He

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition)

    Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition) 由 Hui Li, Wentao Fang, Zhentao Yu, Yousheng Mao, Long-Qi Chen, Jie He, Tiehua Rong, Chun Chen, Haiquan Chen, Ke‐Neng Chen, Ming Du, Yongtao Han, Jian Hu, Jianhua Fu, Xiaobin Hou, Taiqian Gong, Yin Li, Junfeng Liu, Shuoyan Liu, Lijie Tan, Hui Tian, Qun Wang, Jiaqing Xiang, Meiqing Xu, Xin Ye, Bin You, Renquan Zhang, Yan Zhao

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  17. 17
    Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

    Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal S... 由 Hao Wang, Han Tang, Yong Fang, Lijie Tan, Jun Yin, Yaxing Shen, Zhao‐Chong Zeng, Jiangyi Zhu, Yingyong Hou, Ming Du, Jiao Jia, Hongjing Jiang, Lei Gong, Zhigang Li, Jun Liu, Deyao Xie, Wenfeng Li, Changhong Lian, Qiang Zhao, Chun Chen, Bin Zheng, Yongde Liao, Kuo Li, Hecheng Li, Han Wu, Liang Dai, Ke‐Neng Chen

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

    The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104) 由 Lin Xu, Junjie Xi, Wen‐Zhao Zhong, Weimin Mao, Lin Wu, Yi Shen, Yu Liu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Ke Fei, Xiaofei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Hong‐Hong Yan, Xue‐Ning Yang, Yongxing Zhang, Jiacheng Yin, Qun Wang, Yi‐Long Wu

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

    Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial 由 Wen‐Zhao Zhong, Qun Wang, Weimin Mao, Lin Xu, Lin Wu, Yucheng Wei, Yongyu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Shengxiang Ren, Xiaofei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Ke‐Neng Chen, Shidong Xu, Lunxu Liu, Ping Yu, Buhai Wang, Haitao Ma, Jin‐Ji Yang, Hong‐Hong Yan, Xue‐Ning Yang, Si‐Yang Liu, Qing Zhou, Yi‐Long Wu

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

    Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer 由 Patrick M. Forde, Jonathan Spicer, Shun Lü, Mariano Provencio, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen Broderick, Julie R. Brahmer, Steven Swanson, Keith M. Kerr, Changli Wang, Tudor‐Eliade Ciuleanu, Gene B. Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke‐Neng Chen, Moïshe Liberman, Everett E. Vokes, Janis M. Taube, Cécile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, C. Calvet, Nicolas Girard

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: